JMP Securities Reiterates Market Outperform Rating on Aquestive Therapeutics (AQST) Feb 18, 2025 04:23AM
JMP Securities Reiterates Market Outperform Rating on Aquestive Therapeutics (AQST) Oct 8, 2024 08:10AM
Aquestive Therapeutics to Participate in JMP Securities Life Sciences Conference Jun 7, 2022 08:00AM
Aquestive Therapeutics to Participate in JMP Securities Life Sciences Conference Jun 7, 2022 08:00AM
Aquestive Therapeutics (AQST) PT Raised to $17 at JMP Securities Feb 25, 2022 01:49PM


Oct 25, 2021 01:49PM Aquestive Therapeutics (AQST) PT Raised to $15 at JMP Securities, Following Clinical Business Update
Aug 4, 2021 02:49PM Aquestive Therapeutics (AQST) PT Lowered to $14 at JMP Securities, Following Earnings
Jun 9, 2021 08:30AM Aquestive Therapeutics to Participate in JMP Securities and BMO Capital Market Investor Conferences
Jun 9, 2021 08:30AM Aquestive Therapeutics to Participate in JMP Securities and BMO Capital Market Investor Conferences
Jul 16, 2019 03:13AM Aquestive Therapeutics (AQST) PT Lowered to $23 at JMP Securities
Jun 7, 2019 08:30AM Aquestive Therapeutics to Present at Two Upcoming Investor Conferences
Sep 4, 2018 04:22AM Aquestive Therapeutics (AQST) PT Raised to $31 at JMP Securities
Aug 20, 2018 05:06AM JMP Securities Starts Aquestive Therapeutics (AQST) at Market Outperform
Aug 15, 2018 04:00PM Aquestive Therapeutics Announces Closing of Exercise of Underwriters' Over-Allotment Option in Initial Public Offering
Jul 27, 2018 04:00PM Aquestive Therapeutics Announces Closing of Initial Public Offering
Jul 25, 2018 05:47AM Aquestive Therapeutics, Inc. (AQST) Prices 4.5M Share IPO at $15/Sh
Jul 24, 2018 07:54PM Aquestive Therapeutics Announces Pricing of Initial Public Offering